As of Q4'25, CVS reported a net income of USD 2.94B, representing a strong recovery from the previous quarter's significant loss of USD -3.98B in Q3'25. The year-over-year growth rate for Q4'25 stands at 79.0%, highlighting a substantial turnaround compared to the sharp decline observed earlier in the year. Over the period from Q1'23 to Q4'25, CVS's net income exhibited considerable volatility, with notable fluctuations each quarter. After a period of relative stability in 2023, net income declined sharply in Q1'24 and Q3'24, followed by a dramatic loss in Q3'25. However, the company rebounded strongly in Q4'25, achieving both its highest net income and YoY growth rate in the observed timeframe, signaling a potential shift towards renewed profitability.